FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

BEAVER CAROLYN 		2. Issuer Name and Ticker or Trading Symbol

SEQUENOM INC [ SQNM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP & CFO
(Last)          (First)          (Middle)

3595 JOHN HOPKINS COURT 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/10/2016
(Street)

SAN DIEGO, CA 92121
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   6/10/2016     M    3500.0   A $0.0   107567   D    
Common Stock   6/10/2016     P    30000.0   A $1.1   (1) 50000   I   by Spouse  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit     (2) 6/10/2016     M         3500.0      (3)   (4) Common Stock   3500   $0.0   226713   D    

Explanation of Responses:
( 1)  The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $1.0899 to $1.12, inclusive. The reporting person undertakes to provide Sequenom, Inc., any security holder of Sequenom, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote to this Form 4.
( 2)  Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
( 3)  The shares subject to the options shall vest in 48 equal monthly installments commencing on 7/1/14, such that the shares subject to the option are fully vested on 7/1/18.
( 4)  The shares subject to the restricted stock unit began vesting in 4 equal annual installments commencing on 6/10/14, with annual vesting dates on 6/10/15, 6/10/16, 6/10/17 and 6/10/18 such the shares subject to the restricted stock units are fully vested on 6/10/18.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
BEAVER CAROLYN
3595 JOHN HOPKINS COURT
SAN DIEGO, CA 92121

SVP & CFO

Signatures
By: Jeffrey D. Linton, as attorney-in-fact For: Carolyn Beaver 6/13/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Sequenom, Inc. Charts.
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Sequenom, Inc. Charts.